Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

AFZAL SHAKIR

Allopathic & Osteopathic Physicians Urology

NPI
1245851260
CMS profile
11324684
Location
PHILADELPHIA, PA

General Payments · PY2022–2024

$2,012.19

  • Reported across 29 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,213.20

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,113.21 15
Education $99.99 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Medtronic, Inc. $475.11 7
Teleflex LLC $196.12 2
Janssen Biotech, Inc. $155.18 2
AngioDynamics, Inc. $120.62 1
Merck Sharp & Dohme Corporation $117.64 1
Astellas Pharma US Inc $99.99 1
UROGEN PHARMA, INC. $26.29 1
BOSTON SCIENTIFIC CORPORATION $22.25 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $265.17 4
PY2023 $533.82 9
PY2024 $1,213.20 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AngioDynamics, Inc. $120.62 12/13/2024 Food and Beverage Undisputed 01/23/2026 1095095554 CMS
Astellas Pharma US Inc $99.99 01/11/2024 Education Undisputed 01/23/2026 1139388266 CMS
Boston Scientific Corporation $22.25 10/01/2024 Food and Beverage Undisputed 01/23/2026 1092324957 CMS
Janssen Biotech, Inc. $28.63 03/22/2024 Food and Beverage Undisputed 01/23/2026 1078582356 CMS
Janssen Biotech, Inc. $126.55 08/06/2024 Food and Beverage Undisputed 01/23/2026 1078584919 CMS
Medtronic, Inc. $30.00 02/15/2024 Food and Beverage Undisputed 01/23/2026 1117129292 CMS
Medtronic, Inc. $141.81 03/12/2024 Food and Beverage Undisputed 01/23/2026 1117129294 CMS
Medtronic, Inc. $24.13 05/01/2024 Food and Beverage Undisputed 01/23/2026 1117129296 CMS
Medtronic, Inc. $14.83 06/19/2024 Food and Beverage Undisputed 01/23/2026 1117129298 CMS
Medtronic, Inc. $136.53 06/19/2024 Food and Beverage Undisputed 01/23/2026 1117129300 CMS
Medtronic, Inc. $22.10 08/20/2024 Food and Beverage Undisputed 01/23/2026 1117129302 CMS
Medtronic, Inc. $105.71 09/17/2024 Food and Beverage Undisputed 01/23/2026 1117129304 CMS
Merck Sharp & Dohme LLC $117.64 02/01/2024 Food and Beverage Undisputed 01/23/2026 1141622329 CMS
Teleflex LLC $41.48 02/28/2024 Food and Beverage Undisputed 01/23/2026 1142068386 CMS
Teleflex LLC $154.64 02/29/2024 Food and Beverage Undisputed 01/23/2026 1142089485 CMS
UROGEN PHARMA, INC. $26.29 04/08/2024 Food and Beverage Undisputed 01/23/2026 1137928746 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.